ADmit Therapeutics is a biotechnology company that specializes in the development of early Alzheimer's disease diagnosis tests. The company's test is based on an epigenetic analysis in blood samples, covering the analysis of a large number of methylcytosines in mtDNA by next-generation sequencing, enabling medical practitioners with aneasy way to detect early-stage Alzheimer.

Biotechnology

Health Care

Health Diagnostics

Pharmaceutical

ADmit Therapeutics

ADmit Therapeutics' headquarters in Barcelona, Spain

This department oversees organizational strategy, compliance, and stakeholder communication.

Board Governance

This department focuses on leveraging data and advanced analytics to drive insights and support decision-making processes.

ADmit Therapeutics

Org chart

Teams

Board Governance

Data Science and Analytics

Offices

ADmit Therapeutics

Org chart

Teams

Board Governance

Data Science and Analytics

Offices

Related companies